CIM Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,716
| Closed | -$287K | – | 292 |
|
|
2020
Q3 | $287K | Buy |
7,716
+112
| +1% | +$4.17K | 0.11% | 174 |
|
|
2020
Q2 | $390K | Buy |
+7,604
| New | +$390K | 0.16% | 127 |
|
|
2019
Q4 | – | Sell |
-6,486
| Closed | -$238K | – | 253 |
|
|
2019
Q3 | $238K | Hold |
6,486
| – | – | 0.09% | 282 |
|
|
2019
Q2 | $302K | Sell |
6,486
-658
| -9% | -$30.6K | 0.11% | 233 |
|
|
2019
Q1 | $287K | Sell |
7,144
-61
| -0.8% | -$2.45K | 0.11% | 247 |
|
|
2018
Q4 | $331K | Hold |
7,205
| – | – | 0.14% | 187 |
|
|
2018
Q3 | $320K | Hold |
7,205
| – | – | 0.11% | 257 |
|
|
2018
Q2 | $282K | Hold |
7,205
| – | – | 0.1% | 288 |
|
|
2018
Q1 | $521K | Buy |
7,205
+2,911
| +68% | +$210K | 0.18% | 158 |
|
|
2017
Q4 | $283K | Sell |
4,294
-87
| -2% | -$5.73K | 0.1% | 270 |
|
|
2017
Q3 | $220K | Sell |
4,381
-4,387
| -50% | -$220K | 0.08% | 300 |
|
|
2017
Q2 | $406K | Sell |
8,768
-282
| -3% | -$13.1K | 0.14% | 201 |
|
|
2017
Q1 | $320K | Sell |
9,050
-8,900
| -50% | -$315K | 0.11% | 252 |
|
|
2016
Q4 | $225K | Hold |
17,950
| – | – | 0.08% | 308 |
|
|
2016
Q3 | $249K | Buy |
17,950
+680
| +4% | +$9.43K | 0.1% | 293 |
|
|
2016
Q2 | $171K | Buy |
17,270
+1,720
| +11% | +$17K | 0.07% | 282 |
|
|
2016
Q1 | $263K | Buy |
+15,550
| New | +$263K | 0.11% | 217 |
|
|
2015
Q3 | – | Sell |
-2,669
| Closed | -$218K | – | 260 |
|
|
2015
Q2 | $218K | Buy |
+2,669
| New | +$218K | 0.1% | 227 |
|